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journa l homepage: www.e lsev ier .com/ locate / i j idMedical ImageryBehcet’s disease with pulmonary artery aneurysm and Talaromyces
marneffei[(Fig._1)TD$FIG]Fig. 1. Large area of multiple ulcers with purulent secretion in left and right leg (A); chest high resolution computed tomography (HRCT) showed pulmonary artery aneurysm
(PAA) (Fig B, C & D), (the main pulmonary artery was 7.2 centimeter wide), pulmonary embolism (PE) (Fig B & C) and aortic and thoracic aortic calciﬁcation; the skin biopsy
pathology in the right leg conﬁrmed vasculitis (Fig E) (HE  100). The positive Talaromyces marneffei culture of skin lesions in the lower right leg was characterized by
dimorphic fungi growing as a mold at 25 8C (F) with production of a diffusible red pigment, and as yeast at 37 8C on Sabouraud dextrose agar.This case describes an afebrile 62-year-old woman, with
multiple skin lesions for 2 years and paroxysmal chest pain for
10 months. Pathergy test was positive. Mucocutaneous lesions
included oral ulcerations, red papules, and skin ulcerations in the
trunk and lower legs (Fig. 1A) with purulent discharge. C-reactive
protein and D-dimer were 20.49 mg/L & 1851 ng/mL respectively.
Blood gas analysis showed hypoxemia. Blood test results for CD4 &
CD8 lymphocytes, antistreptolysin O, anti-nuclear antibody,
rheumatoid factor, HIV and pathogens in sputum, blood and
bone marrow were negative. Chest high-resolution computedhttp://dx.doi.org/10.1016/j.ijid.2016.10.020
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).tomography (HRCT) showed pulmonary artery aneurysm (PAA)
(Fig. 1B–D), and pulmonary embolism (PE) (Fig. 1B and C). The skin
biopsy pathology conﬁrmed vasculitis (Fig. 1E). Behcet’s disease
(BD)with PAA and PEwas diagnosed. Administration of antibiotics,
anti-coagulant and oral prednisone 40 mg/d for 2-weeks relieved
chest pain, but worsened skin ulcerations around the lower leg.
Culture of skin lesions in the lower right leg was positive for
T. marneffei (Fig. 1F). Her condition improved after intravenous
liposomal amphotericin B for 2 weeks. No relapse of penicilliosis
was seen in the 4 months of continued follow-up.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Medical Imagery / International Journal of Infectious Diseases 54 (2017) 34–35 35Behcet’s disease (BD) is an inﬂammatory vascular disease
causing superﬁcial thrombophlebitis and deep vein thrombosis.1–3
Violating arterial system, especially PAA is rare in BD. This casewas
complicated with PAA and PE. Furthermore, she was infected with
localized Talaromyces marneffei, which, along with BD, has never
been reported previously.4
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